Project Grant HT94252510413
Award Date
9/1/25
Completion Date
8/31/27
Dollars Obligated
$250K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
2323 Riverside Dr., Ottawa, ON K1H 1A1, Canada
Similar Awards
The federal Project Grant award of $249,612.00 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is funding research by Yale University to unravel the causal impact of multiple sclerosis (MS)-associated genetic variants on T cell immune tolerance. The research aims to transform healthcare for military service members, veterans, and the broader public by advancing the understanding of MS pathogenesis through...
This $249,700 Project Grant was awarded by the Defense Health Agency to Memorial University of Newfoundland to support an investigation and therapeutic targeting of metabolic pathways in microglia for efficient remyelination in multiple sclerosis. The funding is provided under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform health care for Service Members and the American public. The two-year...
This federal Project Grant award of $249,999.00, awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, is supporting research conducted by the University of Maryland, Baltimore (UMB) to gain insights into multiple sclerosis pathology. The research project will leverage 7-T MRI and multiomics analysis of serologic samples to advance the understanding of this neurological disorder. The award period runs from August 15, 2024 to August 14,...
The U.S. Defense Health Agency awarded a $320,000 Project Grant under the Military Medical Research and Development (CFDA 12.420) program to the Regents of the University of Michigan. The grant, titled "IMPACT OF THE INTEGRATED STRESS RESPONSE ON VISUAL SYNAPTIC CIRCUITS IN MULTIPLE SCLEROSIS", will support advanced biomedical research focused on transforming healthcare for military service members, veterans, and the broader public. The research, to be conducted from September 1,...
This federal Project Grant award of $319,999.00 from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program supports research at the University of Maryland, Baltimore on the relationship between cortical lesions, meningeal inflammation, and Epstein-Barr virus infection in multiple sclerosis, as observed using 7-T MRI. The award period runs from November 1, 2024 to October 31, 2026. The research aims to advance understanding of the underlying...
This federal Project Grant award of $999,999.00 from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports advanced biomedical research into cell-free DNA epigenetic biomarkers for multiple sclerosis. The award was granted on August 1, 2025 to The Regents of the University of California, San Francisco (UCSF), a prominent academic medical center and research institution. The project aims to transform healthcare for military service...
The federal Project Grant award, valued at $250,000.00, was provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to The Washington University's Office of Sponsored Research Services Division. The award will fund a study on the "SUBCLINICAL PATHOPHYSIOLOGY OF MOTOR PROCESSING IN PEOPLE WITH MULTIPLE SCLEROSIS" over a 2-year period from September 30, 2024 to September 29, 2026. As a prominent private research university, The...
The Defense Health Agency awarded a $998,176 Project Grant to Turun Yliopisto, a Finnish educational institution, to develop new imaging methodology to assess glial cell-driven pathology in multiple sclerosis. The grant is funded through the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The project has a performance period from September 30, 2024 to...
The federal Project Grant award in the amount of $999,793.00 was provided by the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420). This award is supporting research by the Regents of the University of Colorado, specifically the University of Colorado Office of Contracts and Grants Division, to conduct targeted suppression of rodent models for multiple sclerosis (MS). The grant aims to deliver fundamental research and develop specialized data...
This $249,986 federal Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) program supports research by The University of Texas Southwestern Medical Center (UT Southwestern) to understand genetic determinants of multiple sclerosis (MS) progression using longitudinal cohorts. The two-year grant, awarded on September 1, 2024, will enable UT Southwestern to conduct advanced biomedical research focused on transforming...